Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of gastrointestinal diseases
3.2.1.2 Growing adoption of non-invasive tests
3.2.1.3 Rising awareness about gastrointestinal health
3.2.1.4 Technological advancements in diagnostic technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of diagnostic procedures
3.2.2.2 Limited reimbursement policies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
3.8 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Endoscopy
5.3 Blood test
5.4 Immunoglobulin A test
5.5 H. pylori test
5.6 Calprotectin test
5.7 Other test types
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Culture and sensitivity testing
6.3 ELISA
6.4 PCR
6.5 Imaging technologies
6.6 Rapid diagnostic tests
6.7 Other technologies
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Infection
7.3 Gastrointestinal cancer
7.4 Inflammatory bowel disease
7.5 Gastroesophageal reflux disease (GERD)
7.6 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Beckman Coulter, Inc.
10.3 Becton, Dickinson and Company
10.4 bioMerieux
10.5 Bio-Rad Laboratories, Inc.
10.6 DiaSorin S.p.A
10.7 EKF Diagnostics Holdings plc
10.8 F. Hoffmann-La Roche Ltd
10.9 Fujifilm Holdings Corporation
10.10 Meridian Bioscience
10.11 QIAGEN N.V.
10.12 R-Biopharm AG
10.13 Siemens Healthineers AG
10.14 Sysmex Corporation
10.15 Thermo Fisher Scientific Inc.
